Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown. OBJECTIVE: To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamath, Celia C., Giblon, Rachel, Kunneman, Marlene, Lee, Alexander I., Branda, Megan E., Hargraves, Ian G., Sivly, Angela L., Bellolio, Fernanda, Jackson, Elizabeth A., Burnett, Bruce, Gorr, Haeshik, Torres Roldan, Victor D., Spencer-Bonilla, Gabriella, Shah, Nilay D., Noseworthy, Peter A., Montori, Victor M., Brito, Juan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278261/
https://www.ncbi.nlm.nih.gov/pubmed/34255051
http://dx.doi.org/10.1001/jamanetworkopen.2021.16009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278261/
https://www.ncbi.nlm.nih.gov/pubmed/34255051
http://dx.doi.org/10.1001/jamanetworkopen.2021.16009

Ejemplares similares